SCHEMBL8203048

SCHEMBL8203048

Clc1cccc2c1Nc1ccccc1N=C2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
USP2 O75604 1/20 0.38
PPARG P37231 1/20 0.38
KEAP1 Q14145 1/20 0.38
NFE2L2 Q16236 1/20 0.38
HSD17B10 Q99714 1/20 0.38
NR2E3 Q9Y5X4 1/20 0.38
NCOR2 Q9Y618 1/20 0.38
TRPA1 O75762 8/20 0.37
ALDH1A1 P00352 3/20 0.35
MAPT P10636 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
KDM4E B2RXH2 1/20 0.35
TP53 P04637 1/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
HTR5A P47898 3/20 0.33
HTR1A P08908 1/20 0.32
HTR1D P28221 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1759483 0.80 TRPA1 (0.40) MEN1KMT2AUSP2PPARGKEAP1
SCHEMBL309794 0.76 MAPT (0.50) MEN1KMT2AUSP2PPARGKEAP1
SCHEMBL2552199 0.76 MEN1 (0.40) MEN1KMT2AUSP2PPARGKEAP1
SCHEMBL4970782 0.71 TRPA1 (0.38) MEN1KMT2AUSP2PPARGKEAP1
SCHEMBL8202269 0.70 DRD2 (0.42) MEN1KMT2AUSP2PPARGKEAP1
SCHEMBL8203995 0.70 BCHE (0.44) MEN1KMT2AUSP2PPARGKEAP1
SCHEMBL3370805 0.68 SMN1; SMN2 (0.44) MEN1KMT2AUSP2PPARGKEAP1
SCHEMBL8203046 0.68 GAA (0.41) MEN1KMT2AUSP2PPARGKEAP1
SCHEMBL11162416 0.67 MEN1 (0.44) MEN1KMT2AUSP2PPARGKEAP1
SCHEMBL3521082 0.67 DRD2 (0.43) MEN1KMT2AHSD17B10TRPA1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6103715-A COMPOUNDS THAT BIND TO THE DOPAMINE D4 RECEPTOR AND THEIR USE AS ANXIOLYTIC AGENTS, TREATMENT FOR SCHIZOPHRENIA, AND DRUG SCREENING; SIDE EFFECT REDUCTIOON ALLELIX BIOPHARMACEUTICALS INC. (CA) 2000-08-15 US disclosed
US-5968478-A DIBENZOTHIEPINE AS NEUROTRANSMITTERS AND FOR DRUG SCREENING AND TREATMENT OF SCHIZOPHRENIA ALLELIX BIOPHARMACEUTICALS, INC. (CA) 1999-10-19 US disclosed
US-5538965-A TREATMENT OF PSYCHOLOGICAL DISORDERS SUCH AS SCHIZOPHRENIA AND ANXIETY ALLELIX BIOPHARMACEUTICALS INC. (CA) 1996-07-23 US disclosed
WO-1996018622-A1 N-METHYL PIPERAZINE COMPOUNDS HAVING DOPAMINE RECEPTOR AFFINITY ALLELIX BIOPHARMACEUTICALS INC. (US) 1996-06-20 WO disclosed